Trafalis, D.T.;                     Sagredou, S.;                     Dalezis, P.;                     Voura, M.;                     Fountoulaki, S.;                     Nikoleousakos, N.;                     Almpanakis, K.;                     Deligiorgi, M.V.;                     Sarli, V.    
        Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics 2021, 13, 493.
    https://doi.org/10.3390/pharmaceutics13040493
    AMA Style
    
                                Trafalis DT,                                 Sagredou S,                                 Dalezis P,                                 Voura M,                                 Fountoulaki S,                                 Nikoleousakos N,                                 Almpanakis K,                                 Deligiorgi MV,                                 Sarli V.        
                Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics. 2021; 13(4):493.
        https://doi.org/10.3390/pharmaceutics13040493
    
    Chicago/Turabian Style
    
                                Trafalis, Dimitrios T.,                                 Sofia Sagredou,                                 Panayiotis Dalezis,                                 Maria Voura,                                 Stella Fountoulaki,                                 Nikolaos Nikoleousakos,                                 Konstantinos Almpanakis,                                 Maria V. Deligiorgi,                                 and Vasiliki Sarli.        
                2021. "Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation" Pharmaceutics 13, no. 4: 493.
        https://doi.org/10.3390/pharmaceutics13040493
    
    APA Style
    
                                Trafalis, D. T.,                                 Sagredou, S.,                                 Dalezis, P.,                                 Voura, M.,                                 Fountoulaki, S.,                                 Nikoleousakos, N.,                                 Almpanakis, K.,                                 Deligiorgi, M. V.,                                 & Sarli, V.        
        
        (2021). Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation. Pharmaceutics, 13(4), 493.
        https://doi.org/10.3390/pharmaceutics13040493